Marijuanna has been used as supplementary treatment for many neurological and psychological conditions for centuries. It’s first reported usage can be traced as far back as 2,600 BC in a Chinese pharmacopoeia. But only in recent years have we begun to scratch the surface of the potential medical benefits of marijuana.
In this publication, we explore the most studied extracts from the cannabis sativa subspecies hemp and marijuana: phytocannabinoids, cannabidiol (CBD), and delta‐9‐tetrahydrocannabinol (Δ9‐THC) as well as its positive effects on users suffering from Parkinson’s disease (PD), Alzheimer’s disease (AD), multiple sclerosis (MS) and PTSD.